EXOSYSTEMS was founded in 2017 as a spin-off company from ETRI (Electronics and Telecommunications Research Institute). Based on robotics and artificial intelligence technologies, we are a digital healthcare solution company dedicated to creating a new paradigm in health management. We possess independent technological capabilities across both hardware and software domains and have established a leading clinical research pipeline, solidifying our position as a top-tier technology-driven startup.

EXOSYSTEMS specializes in providing digital health intervention solutions and digital biomarker analysis technologies based on biosignal data for neuromuscular disorders. Starting with digital care products for musculoskeletal health management, we are expanding our solutions to address a wide range of chronic diseases, aiming to become a leading player in the global digital healthcare market.

In addition, EXOSYSTEMS offers AI-powered digital healthcare solutions that integrate prevention, early diagnosis, and treatment outcome monitoring through biosignal-based neuromuscular digital biomarker technologies. Through these innovations, we are driving the future of global digital healthcare transformation.